CD133 Innovation

CD133 Innovation is rated 3 out of 5 in the category biotechnology. Read and write reviews about CD133 Innovation. CD133 Innovation Limited is committed to pursuing a precise and sensitive detection of circulating tumour cells (CTC) through our bio-imaging technology together with the current early cancer detection method. Neurostem imaging is our company designed magnetic nano-sized contrast agent. Our technology enables the visualisation of target cells or neural stem cells precisely, also makes real-time cell tracking possible under Magnetic Resonance Imaging. With our strategic designed nanoparticles, the detection sensitivity of CTC could be highly enhanced, thus providing a significant prognostic information for patients.